Company Filing History:

5 out of 1,455

Sanofi

Years Active: 1980-1986

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4624952 - Pyridazine and pyrimidine compounds active on the central nervous system (1986-11-25),

2. 4613603 - Compounds with a nitrogen-containing heterocyclic nucleus, and drugs in (1986-09-23),

3. 4587245 - Method of treating neuropsychic disturbances by benzodiazepine (1986-05-06),

4. 4581358 - Triazolo-pyrimidine derivatives, a process for preparing them and their (1986-04-08),

5. 4542136 - 2-(1-Piperazinyl) pyrimidines, their salts and pharmaceutical (1985-09-17),

6. 4540696 - 1-Piperazinyl 4-phenylquinazoline compounds having antidepressant (1985-09-10),

7. 4499092 - Derivatives of 4-phenyl quinazoline active on the central nervous system (1985-02-12),

8. 4235897 - Benzodiazepine derivatives and pharmaceutical compositions thereof (1980-11-25),

Title: The Innovative Mind of Andre Hallot: Contributions to Neuroscience

Introduction: Andre Hallot is a distinguished inventor based in St. Gely Du Fesc, France. With an impressive portfolio of 8 patents, he has made significant contributions to the field of compounds affecting the central nervous system. His work has enhanced our understanding of chemical compositions that could lead to advanced therapeutic solutions.

Latest Patents: One of Andre Hallot's latest patents focuses on pyridazine and pyrimidine compounds that are active on the central nervous system. This invention involves compounds of a specific formula featuring diverse nitrogen components and saturated heterocycles, which exhibit promising pharmacological activity. Additionally, he has developed nitrogen-containing heterocyclic compounds that serve as the backbone for new drugs targeting critical health issues.

Career Highlights: Throughout his career, Hallot has collaborated with renowned pharmaceutical companies such as Sanofi. His work has contributed to the development of various therapeutic agents, particularly in the realms of neurology and psychiatry. Hallot’s innovative approach towards drug formulation underscores his commitment to improving patient outcomes through scientific exploration.

Collaborations: Andre has had the opportunity to work alongside esteemed colleagues, including Kathleen Biziere and Jean-Pierre Chambon. Their collective expertise has been instrumental in advancing research and development efforts within the pharmaceutical landscape. The synergy of their talents exemplifies the of power teamwork in driving innovation.

Conclusion: Andre Hallot's dedication to his craft and his numerous patents underscore his influential role as an inventor in the pharmaceutical industry. His contributions, particularly in the development of compounds that interact with the central nervous system, highlight the potential of innovative science to address complex medical challenges. Hallot continues to pave the way for future discoveries, showcasing the importance of innovation in improving healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com